Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Nephros reports preliminary Q2 revenue $1.6M, consensus $2.24M » 07:32
07/08/20
07/08
07:32
07/08/20
07:32
NEPH

Nephros

$8.05 /

-0.02 (-0.25%)

Nephros ended the quarter…

Nephros ended the quarter with approximately $7M in cash on a consolidated basis. "The headwinds from COVID-19 stopped our four-year quarterly growth streak. We and our customers are adapting to the new normal, and we remain optimistic about our ability to return to our high growth rate path," commented Daron Evans, president and CEO. "We strongly believe that a new level of attention will be focused on bacteria and virus by our customers as their attention expands beyond a focus on COVID-19. Additionally, we are confident that our new pathogen detection product line will gain traction in the market. These products include PluraPath(TM), our real-time, field-based pathogen detection system, SequaPath(TM), our comprehensive portable water screening and analysis system - which we anticipate launching soon - and DialyPath(TM), our real-time test for dialysis clinics that will detect and quantify endotoxin-producing Gram-negative bacteria. As with the last quarter, potential negative developments could include additional delays in acquiring new customers, particularly if reopening takes longer than anticipated or if some areas in the U.S. experience new restrictions in the operations of businesses in healthcare and hospitality sectors in response to increased COVID-19 cases."

ShowHide Related Items >><<
NEPH Nephros
$8.05 /

-0.02 (-0.25%)

NEPH Nephros
$8.05 /

-0.02 (-0.25%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
NEPH Nephros
$8.05 /

-0.02 (-0.25%)

  • 31
    Jan
Over a week ago
Hot Stocks
Nephros to join Russell Microcap Index » 07:45
06/18/20
06/18
07:45
06/18/20
07:45
NEPH

Nephros

$8.20 /

+0.1 (+1.23%)

Nephros announced that it…

Nephros announced that it is set to join the Russell Microcap Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according to a preliminary list of additions posted June 5.

ShowHide Related Items >><<
NEPH Nephros
$8.20 /

+0.1 (+1.23%)

NEPH Nephros
$8.20 /

+0.1 (+1.23%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
NEPH Nephros
$8.20 /

+0.1 (+1.23%)

Conference/Events
Benchmark to hold a virtual conference » 08:18
06/15/20
06/15
08:18
06/15/20
08:18
AMED

Amedisys

$170.17 /

-0.15 (-0.09%)

, BEAT

BioTelemetry

$46.37 /

+1.34 (+2.98%)

, CATS

Catasys

$19.86 /

+1.42 (+7.70%)

, EXAS

Exact Sciences

$85.39 /

-3.05 (-3.45%)

, FLXN

Flexion

$11.25 /

+0.5 (+4.65%)

, HURN

Huron

$41.72 /

+0.48 (+1.16%)

, NVTA

Invitae

$16.17 /

+0.27 (+1.70%)

, LGND

Ligand

$109.29 /

-1.24 (-1.12%)

, LVGO

Livongo Health

$60.13 /

+1.17 (+1.98%)

, MTBC

MTBC

$6.70 /

+0.285 (+4.45%)

, NEO

NeoGenomics

$27.07 /

+1.08 (+4.16%)

, NEPH

Nephros

$7.98 /

+0.48 (+6.40%)

, SEEL

Seelos Therapeutics

$1.21 /

+0.135 (+12.56%)

, STAA

Staar Surgical

$42.79 /

+1.67 (+4.06%)

, TRHC

Tabula Rasa HealthCare

$53.17 /

+0.52 (+0.99%)

, VNRX

VolitionRx

$2.89 /

+ (+0.00%)

Virtual Healthcare 1:1…

Virtual Healthcare 1:1 Conference will be held on June 15-16 beginning at 9 am. Webcast Link

ShowHide Related Items >><<
VNRX VolitionRx
$2.89 /

+ (+0.00%)

TRHC Tabula Rasa HealthCare
$53.17 /

+0.52 (+0.99%)

STAA Staar Surgical
$42.79 /

+1.67 (+4.06%)

SEEL Seelos Therapeutics
$1.21 /

+0.135 (+12.56%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

NEPH Nephros
$7.98 /

+0.48 (+6.40%)

NEO NeoGenomics
$27.07 /

+1.08 (+4.16%)

MTBC MTBC
$6.70 /

+0.285 (+4.45%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

LGND Ligand
$109.29 /

-1.24 (-1.12%)

HURN Huron
$41.72 /

+0.48 (+1.16%)

FLXN Flexion
$11.25 /

+0.5 (+4.65%)

EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

CATS Catasys
$19.86 /

+1.42 (+7.70%)

BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

AMED Amedisys
$170.17 /

-0.15 (-0.09%)

AMED Amedisys
$170.17 /

-0.15 (-0.09%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

01/07/20 SunTrust
BioTelemetry initiated with a Buy at SunTrust
11/06/19 Lake Street
BioTelemetry price target lowered to $80 from $90 at Lake Street
08/02/19
BioTelemetry downgraded to Market Perform on moderating growth at Raymond James
08/02/19 Raymond James
BioTelemetry downgraded to Market Perform from Outperform at Raymond James
CATS Catasys
$19.86 /

+1.42 (+7.70%)

05/06/20 RBC Capital
Short report targeting Catasys 'doesn't break new ground,' says RBC Capital
04/20/20 RBC Capital
Catasys initiated with an Outperform at RBC Capital
04/20/20 Canaccord
Catasys price target raised to $35 from $26 at Canaccord
03/16/20 Canaccord
Canaccord says three focus names names have limited COVID-19 impact
EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

05/13/20 Evercore ISI
Exact Sciences comments imply volumes last week down 40% YoY, says Evercore ISI
05/07/20 Craig-Hallum
Exact Sciences price target lowered to $92 from $99 at Craig-Hallum
05/07/20 Canaccord
Exact Sciences price target lowered to $110 from $120 at Canaccord
04/22/20 Baird
Exact Sciences price target lowered to $90 from $100 at Baird
FLXN Flexion
$11.25 /

+0.5 (+4.65%)

05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
05/26/20 Guggenheim
Flexion initiated with a Buy at Guggenheim
05/08/20 Needham
Flexion price target lowered to $20 from $30 at Needham
04/02/20 Benchmark
Flexion price target lowered to $17 from $25 at Benchmark
HURN Huron
$41.72 /

+0.48 (+1.16%)

05/01/20 Benchmark
Huron downgraded to Hold on limited visibility at Benchmark
05/01/20 Benchmark
Huron downgraded to Hold from Buy at Benchmark
01/06/20 SunTrust
Huron price target raised to $80 from $74 at SunTrust
10/31/19 Barrington
Huron price target raised to $76 from $68 at Barrington
NVTA Invitae
$16.17 /

+0.27 (+1.70%)

05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
01/28/20 Cowen
More flexible Medicare coverage for NGS a positive for Invitae, says Cowen
LGND Ligand
$109.29 /

-1.24 (-1.12%)

06/02/20 Craig-Hallum
Ligand stock should move higher, says Craig-Hallum
04/29/20 Craig-Hallum
Ligand has 'significant upside' if remdesivir is approved, says Craig-Hallum
04/08/20 H.C. Wainwright
Ligand price target lowered to $229 from $237 at H.C. Wainwright
04/06/20 H.C. Wainwright
H.C. Wainwright says Captisol a 'key focus' for Ligand, reiterates Buy
LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

06/12/20 SVB Leerink
Livongo Health price target raised to $65 from $55 at SVB Leerink
06/05/20 Cowen
Livongo Health initiated with Outperform at Cowen
06/03/20 Canaccord
Livongo Health price target raised to $69 from $65 at Canaccord
05/22/20 JPMorgan
Livongo Health price target raised to $63 from $36 at JPMorgan
MTBC MTBC
$6.70 /

+0.285 (+4.45%)

06/02/20 Ladenburg
MTBC initiated with a Buy at Ladenburg
03/03/20
LD Micro to hold a virtual conference
03/02/20
Fly Intel: Top five analyst downgrades
03/02/20 H.C. Wainwright
MTBC downgraded to Neutral from Buy at H.C. Wainwright
NEO NeoGenomics
$27.07 /

+1.08 (+4.16%)

04/21/20 Stephens
NeoGenomics resumed with an Overweight at Stephens
03/17/20 Needham
Needham adds NeoGenomics to Conviction List, boosts target to $33
03/02/20 Craig-Hallum
NeoGenomics resumed with a Buy at Craig-Hallum
03/02/20 Raymond James
NeoGenomics price target raised to $32 from $28 at Raymond James
NEPH Nephros
$7.98 /

+0.48 (+6.40%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
SEEL Seelos Therapeutics
$1.21 /

+0.135 (+12.56%)

11/18/19 H.C. Wainwright
Seelos Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
11/14/19 Benchmark
Seelos Therapeutics initiated with a Speculative Buy at Benchmark
STAA Staar Surgical
$42.79 /

+1.67 (+4.06%)

06/15/20 Jefferies
Staar Surgical initiated with a Buy at Jefferies
03/04/20
BTIG healthcare analysts to hold an analyst/industry conference call
01/31/20 Benchmark
Too early to call China emergency impact on Staar Surgical, says Benchmark
TRHC Tabula Rasa HealthCare
$53.17 /

+0.52 (+0.99%)

04/20/20 RBC Capital
Tabula Rasa HealthCare initiated with an Outperform at RBC Capital
04/13/20 Stifel
Tabula Rasa HealthCare seen as 'one of most defensive names in HCIT' at Stifel
04/13/20 SVB Leerink
Tabula Rasa HealthCare initiated with an Outperform at SVB Leerink
03/31/20 Baird
Tabula Rasa HealthCare resilient in face of COVID-19, says Baird
VNRX VolitionRx
$2.89 /

+ (+0.00%)

05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
TRHC Tabula Rasa HealthCare
$53.17 /

+0.52 (+0.99%)

STAA Staar Surgical
$42.79 /

+1.67 (+4.06%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

NEPH Nephros
$7.98 /

+0.48 (+6.40%)

NEO NeoGenomics
$27.07 /

+1.08 (+4.16%)

MTBC MTBC
$6.70 /

+0.285 (+4.45%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

LGND Ligand
$109.29 /

-1.24 (-1.12%)

HURN Huron
$41.72 /

+0.48 (+1.16%)

FLXN Flexion
$11.25 /

+0.5 (+4.65%)

EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

CATS Catasys
$19.86 /

+1.42 (+7.70%)

BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

AMED Amedisys
$170.17 /

-0.15 (-0.09%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

VNRX VolitionRx
$2.89 /

+ (+0.00%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

LGND Ligand
$109.29 /

-1.24 (-1.12%)

FLXN Flexion
$11.25 /

+0.5 (+4.65%)

VNRX VolitionRx
$2.89 /

+ (+0.00%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

CATS Catasys
$19.86 /

+1.42 (+7.70%)

BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

Over a month ago
Conference/Events
Nephros management to virtually meet with Benchmark » 04:55
05/22/20
05/22
04:55
05/22/20
04:55
NEPH

Nephros

$7.55 /

-0.045 (-0.59%)

Virtual Meeting to be…

Virtual Meeting to be held on May 22 hosted by Benchmark.

ShowHide Related Items >><<
NEPH Nephros
$7.55 /

-0.045 (-0.59%)

NEPH Nephros
$7.55 /

-0.045 (-0.59%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
NEPH Nephros
$7.55 /

-0.045 (-0.59%)

Conference/Events
Nephros management to virtually meet with Benchmark » 13:56
05/19/20
05/19
13:56
05/19/20
13:56
NEPH

Nephros

$7.26 /

+0.055 (+0.76%)

Virtual Meeting to be…

Virtual Meeting to be held on May 22 hosted by Benchmark.

ShowHide Related Items >><<
NEPH Nephros
$7.26 /

+0.055 (+0.76%)

NEPH Nephros
$7.26 /

+0.055 (+0.76%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
NEPH Nephros
$7.26 /

+0.055 (+0.76%)

Over a quarter ago
Earnings
Nephros withdraws 2020 revenue guidance » 07:42
04/02/20
04/02
07:42
04/02/20
07:42
NEPH

Nephros

$6.25 /

-0.03 (-0.48%)

The company said,…

The company said, "Given the uncertainties around the coronavirus pandemic and its potential impacts on our business, both positive and negative, we are withdrawing our previous revenue guidance for 2020. Potential positive impacts include increased demand for both our water filters that help protect patients from waterborne pathogens, including bacteria and viruses, and PluraPath, our recently launched real-time, field-based pathogen detection system. Potential negative impacts include possible interruptions to our supply chain and delays in new customer acquisition activities." Nephros ended the quarter with approximately $8.9M in cash on a consolidated basis.

ShowHide Related Items >><<
NEPH Nephros
$6.25 /

-0.03 (-0.48%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
Earnings
Nephros expects Q1 revenue $2.6M, two est. $3.12M » 07:42
04/02/20
04/02
07:42
04/02/20
07:42
NEPH

Nephros

$6.25 /

-0.03 (-0.48%)

"In this…

"In this unprecedented time of crisis, we are pleased that the company's growth continued in the first quarter," said Daron Evans, President and CEO of Nephros. "These results represent our 15th consecutive quarter of year-on-year sales growth, with a current average of 62%. While the coronavirus pandemic adds uncertainty and risk to all companies, we have seen continued demand for our products and believe we are well-positioned for continued growth through this difficult time and beyond."

ShowHide Related Items >><<
NEPH Nephros
$6.25 /

-0.03 (-0.48%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
Conference/Events
LD Micro to hold a virtual conference » 09:25
03/04/20
03/04
09:25
03/04/20
09:25
DGLY

Digital Ally

$1.10 /

-0.02 (-1.79%)

, PLIN

China Xiangtai Food

$2.48 /

+0.01 (+0.40%)

, NEPH

Nephros

$9.00 /

+0.1 (+1.12%)

, DTSS

Datasea

$2.27 /

+0.045 (+2.02%)

, CTXR

Citius Pharmaceuticals

$0.68 /

-0.015 (-2.17%)

, ARTH

Arch Therapeutics

$0.00 /

+ (+0.00%)

, ISDR

Issuer Direct

$11.10 /

-0.19 (-1.68%)

, CTHR

Charles & Colvard

$0.86 /

+0.005 (+0.58%)

, OESX

Orion Energy

$4.61 /

-0.03 (-0.65%)

, SGLB

Sigma Labs

$5.76 /

-0.18 (-3.03%)

, SONG

Akazoo

$4.35 /

-0.23 (-5.02%)

, GNPX

Genprex

$4.41 /

-0.345 (-7.26%)

, ADXS

Advaxis

$0.83 /

-0.0611 (-6.88%)

, LAKE

Lakeland Industries

$17.77 /

-0.42 (-2.31%)

, QBAK

Qualstar

$4.75 /

+0.2 (+4.40%)

, DPW

DPW Holdings

$1.19 /

+0.125 (+11.74%)

3rd Annual LD Micro…

3rd Annual LD Micro Virtual Conference will be held on March 3-4 with webcasted company presentations to begin on March 4 at 9:40 am. Webcast Link

ShowHide Related Items >><<
DGLY Digital Ally
$1.10 /

-0.02 (-1.79%)

PLIN China Xiangtai Food
$2.48 /

+0.01 (+0.40%)

NEPH Nephros
$9.00 /

+0.1 (+1.12%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
DTSS Datasea
$2.27 /

+0.045 (+2.02%)

CTXR Citius Pharmaceuticals
$0.68 /

-0.015 (-2.17%)

ARTH Arch Therapeutics
$0.00 /

+ (+0.00%)

ISDR Issuer Direct
$11.10 /

-0.19 (-1.68%)

CTHR Charles & Colvard
$0.86 /

+0.005 (+0.58%)

06/12/19 Roth Capital
Charles & Colvard initiated with a Buy at Roth Capital
OESX Orion Energy
$4.61 /

-0.03 (-0.65%)

02/07/20 B. Riley FBR
Orion Energy reported another strong quarter, says B. Riley FBR
02/07/20 H.C. Wainwright
Orion Energy price target raised to $7 from $4.50 at H.C. Wainwright
01/29/20 Craig-Hallum
Orion Energy price target raised to $6 from $4 at Craig-Hallum
12/06/19 Craig-Hallum
Craig-Hallum predicts 'sizable' follow-on order coming for Orion from Home Depot
SGLB Sigma Labs
$5.76 /

-0.18 (-3.03%)

08/16/19 Aegis
Sigma Labs initiated with a Buy at Aegis
SONG Akazoo
$4.35 /

-0.23 (-5.02%)

10/16/19 Noble Capital
Akazoo initiated with an Outperform at Noble Capital
10/07/19
Craig-Hallum bullish on Akazoo, initiates with a Buy
10/07/19 Craig-Hallum
Akazoo initiated with a Buy rating at Craig-Hallum
09/12/19 Macquarie
Akazoo initiated with an Outperform at Macquarie
GNPX Genprex
$4.41 /

-0.345 (-7.26%)

04/01/19 Maxim
Genprex downgraded to Hold from Buy at Maxim
ADXS Advaxis
$0.83 /

-0.0611 (-6.88%)

LAKE Lakeland Industries
$17.77 /

-0.42 (-2.31%)

QBAK Qualstar
$4.75 /

+0.2 (+4.40%)

DPW DPW Holdings
$1.19 /

+0.125 (+11.74%)

Conference/Events
LD Micro to hold a virtual conference » 07:47
03/04/20
03/04
07:47
03/04/20
07:47
DGLY

Digital Ally

$1.10 /

-0.02 (-1.79%)

, PLIN

China Xiangtai Food

$2.48 /

+0.01 (+0.40%)

, NEPH

Nephros

$9.00 /

+0.1 (+1.12%)

, DTSS

Datasea

$2.27 /

+0.045 (+2.02%)

, CTXR

Citius Pharmaceuticals

$0.68 /

-0.015 (-2.17%)

, ARTH

Arch Therapeutics

$0.00 /

+ (+0.00%)

, ISDR

Issuer Direct

$11.10 /

-0.19 (-1.68%)

, CTHR

Charles & Colvard

$0.86 /

+0.005 (+0.58%)

, OESX

Orion Energy

$4.61 /

-0.03 (-0.65%)

, SGLB

Sigma Labs

$5.76 /

-0.18 (-3.03%)

, SONG

Akazoo

$4.35 /

-0.23 (-5.02%)

, GNPX

Genprex

$4.41 /

-0.345 (-7.26%)

, ADXS

Advaxis

$0.83 /

-0.0611 (-6.88%)

, LAKE

Lakeland Industries

$17.77 /

-0.42 (-2.31%)

, QBAK

Qualstar

$4.75 /

+0.2 (+4.40%)

, DPW

DPW Holdings

$1.19 /

+0.125 (+11.74%)

3rd Annual LD Micro…

3rd Annual LD Micro Virtual Conference will be held on March 3-4 with webcasted company presentations to begin on March 4 at 9:40 am. Webcast Link

ShowHide Related Items >><<
DGLY Digital Ally
$1.10 /

-0.02 (-1.79%)

PLIN China Xiangtai Food
$2.48 /

+0.01 (+0.40%)

NEPH Nephros
$9.00 /

+0.1 (+1.12%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
DTSS Datasea
$2.27 /

+0.045 (+2.02%)

CTXR Citius Pharmaceuticals
$0.68 /

-0.015 (-2.17%)

ARTH Arch Therapeutics
$0.00 /

+ (+0.00%)

ISDR Issuer Direct
$11.10 /

-0.19 (-1.68%)

CTHR Charles & Colvard
$0.86 /

+0.005 (+0.58%)

06/12/19 Roth Capital
Charles & Colvard initiated with a Buy at Roth Capital
OESX Orion Energy
$4.61 /

-0.03 (-0.65%)

02/07/20 B. Riley FBR
Orion Energy reported another strong quarter, says B. Riley FBR
02/07/20 H.C. Wainwright
Orion Energy price target raised to $7 from $4.50 at H.C. Wainwright
01/29/20 Craig-Hallum
Orion Energy price target raised to $6 from $4 at Craig-Hallum
12/06/19 Craig-Hallum
Craig-Hallum predicts 'sizable' follow-on order coming for Orion from Home Depot
SGLB Sigma Labs
$5.76 /

-0.18 (-3.03%)

08/16/19 Aegis
Sigma Labs initiated with a Buy at Aegis
SONG Akazoo
$4.35 /

-0.23 (-5.02%)

10/16/19 Noble Capital
Akazoo initiated with an Outperform at Noble Capital
10/07/19
Craig-Hallum bullish on Akazoo, initiates with a Buy
10/07/19 Craig-Hallum
Akazoo initiated with a Buy rating at Craig-Hallum
09/12/19 Macquarie
Akazoo initiated with an Outperform at Macquarie
GNPX Genprex
$4.41 /

-0.345 (-7.26%)

04/01/19 Maxim
Genprex downgraded to Hold from Buy at Maxim
ADXS Advaxis
$0.83 /

-0.0611 (-6.88%)

LAKE Lakeland Industries
$17.77 /

-0.42 (-2.31%)

QBAK Qualstar
$4.75 /

+0.2 (+4.40%)

DPW DPW Holdings
$1.19 /

+0.125 (+11.74%)

Earnings
Nephros reports Q4 adjusted EBITDA $376,000 » 16:24
02/27/20
02/27
16:24
02/27/20
16:24
NEPH

Nephros

$8.36 /

+0.11 (+1.33%)

Reports Q4 revenue $3.2M,…

Reports Q4 revenue $3.2M, consensus $2.84M.

ShowHide Related Items >><<
NEPH Nephros
$8.36 /

+0.11 (+1.33%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.